Inter Partes Reviews for the Life Sciences: Strategic Approaches for Petitioners and Patent Owners

BIOCOM Breakfast

23 Jun 2016 08:00 a.m. - 10:00 a.m.

Morrison & Foerster LLP
12531 High Bluff Drive, Suite 100
San Diego, CA 92130-2040

More than 4,100 petitions for inter partes review (IPR) have been filed since IPR became available as a new procedure for challenging patent validity. Only a small percentage of those petitions, however, have been filed on biological/pharmaceutical patents and those at issue in ANDA, or Hatch-Waxman, litigation. Although challenging patents using the IPR process has been a highly effective strategy in general, the success rate for those challenging pharmaceutical and life sciences patents has fallen well short of the average.

This seminar will highlight several concrete strategies for IPR petitions in pharmaceutical and biotechnology cases. With the increasing number of orders and final decisions issuing from the Patent Trials and Appeal Board (PTAB), there is much for patent prosecutors and litigators alike to learn.

Topics Will Include:

  • America Invents Act (AIA) Statistics
  • Strategies for Crafting a Successful Life Sciences IPR
  • A Case Study of a Life Sciences IPR
  • PTAB “Pet Peeves”: Practice Recommendations
  • Real Party in Interest and Privacy Issues


  • 8:00am-8:30am Breakfast & Networking
  • 8:30am-9:30am Program
  • 9:30am-10:00am Q&A and Networking



Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.